公开(公告)号：US08331074B2

公开(公告)日：2012-12-11

申请号：US12828808

申请日：2010-07-01

申请人： Chao Zhang ,  Jeffrey J. Kester ,  Charles W. Daley

发明人： Chao Zhang ,  Jeffrey J. Kester ,  Charles W. Daley

IPC分类号： H02H1/04

CPC分类号： H01C7/123

摘要： An electrical assembly having an elongated electrical component, such as a surge arrester, coupled to a grading device for distributing an electric field along the electrical component as a continuous operating voltage is applied to the electrical component. The grading device includes a grading body that is coupled to the electrical component. The grading body includes semi-conductive materials. The semi-conductive materials can be nonmetallic. The grading device has improved flashover resistance over conventional metal grading devices.

摘要翻译： 具有细长电气部件的电气组件，例如避雷器，耦合到分级装置，用于沿着电气部件分配电场作为连续工作电压被施加到电气部件。 分级装置包括耦合到电气部件的分级体。 分级体包括半导体材料。 半导体材料可以是非金属的。 分级装置具有比常规金属分级装置更好的闪络阻力。

公开(公告)号：US20120002339A1

公开(公告)日：2012-01-05

申请号：US12828808

申请日：2010-07-01

申请人： Chao Zhang ,  Jeffrey J. Kester ,  Charles W. Daley

发明人： Chao Zhang ,  Jeffrey J. Kester ,  Charles W. Daley

IPC分类号： H02H1/00

CPC分类号： H01C7/123

摘要： An electrical assembly having an elongated electrical component, such as a surge arrester, coupled to a grading device for distributing an electric field along the electrical component during operation. The grading device includes a grading body and a means for securing the grading body to the electrical component. The grading body, the securing means, or both include semi-conductive materials. The semi-conductive materials can be nonmetallic. The grading device has improved flashover resistance over conventional metal grading devices.

摘要翻译： 电气组件具有细长的电气部件，例如避雷器，其耦合到分级装置，用于在操作期间沿电气部件分布电场。 分级装置包括分级体和用于将分级体固定到电气部件的装置。 分级体，固定装置或两者均包括半导体材料。 半导体材料可以是非金属的。 分级装置具有比常规金属分级装置更好的闪络阻力。

公开(公告)号：USD968138S1

公开(公告)日：2022-11-01

申请号：US29832941

申请日：2022-03-31

申请人： Chao Zhang

设计人： Chao Zhang

公开(公告)号：US09734867B2

公开(公告)日：2017-08-15

申请号：US13069136

申请日：2011-03-22

申请人： Yu Huang ,  Chao Zhang ,  Hong Heather Yu ,  Dongjing Shan

发明人： Yu Huang ,  Chao Zhang ,  Hong Heather Yu ,  Dongjing Shan

IPC分类号： H04N7/10 ,  G11B27/031 ,  G11B27/28 ,  H04N21/233 ,  H04N21/234 ,  H04N21/845

CPC分类号： G11B27/031 ,  G11B27/28 ,  H04N21/233 ,  H04N21/23418 ,  H04N21/23424 ,  H04N21/8455 ,  H04N21/8456

摘要： In accordance with an embodiment of the present invention, a method for inserting secondary content into a media stream includes dividing the media stream having a plurality of frames into a plurality of shots at a processor. The method further includes grouping consecutive shots from the plurality of shots into a plurality of scenes. A first list of insertion points is generated for introducing the secondary content. The insertion points of the first list are boundaries between consecutive scenes in the plurality of scenes. An average insertion point saliency of the media stream is generated at the insertion points in the first list. A second list of insertion points is then generated. The insertion points in the second list are arranged to maximize a function of the average insertion point saliency and a distance between each insertion point in the second list with other insertion points in the second list.

公开(公告)号：US09512125B2

公开(公告)日：2016-12-06

申请号：US11719722

申请日：2005-11-21

申请人： Kevan M. Shokat ,  Nikolai Sepetov ,  Chao Zhang ,  Heinz W. Gschwend ,  Eric J. Kunkel

发明人： Kevan M. Shokat ,  Nikolai Sepetov ,  Chao Zhang ,  Heinz W. Gschwend ,  Eric J. Kunkel

IPC分类号： C07D487/04 ,  A61K31/519 ,  A61P29/00 ,  A61P35/00 ,  A61P9/00 ,  A61P19/02 ,  A61P25/28 ,  A61P25/16 ,  A61P25/22 ,  A61P25/24 ,  A61P9/10

CPC分类号： C07D487/04

摘要： The present invention provides anti-inflammatory compounds useful in the treatment of diseases and conditions in which inflammation is involved in disease progression or the manifestation of symptoms of the disease or condition.

摘要翻译： 本发明提供了抗炎化合物，其可用于治疗疾病进展中发生炎症或疾病或病症症状的疾病和病症。

公开(公告)号：US20140279818A1

公开(公告)日：2014-09-18

申请号：US14216449

申请日：2014-03-17

申请人： Albert Xin Jiang ,  Zhengyu Yin ,  Chao Zhang ,  Milind Tambe ,  Sarit Kraus

发明人： Albert Xin Jiang ,  Zhengyu Yin ,  Chao Zhang ,  Milind Tambe ,  Sarit Kraus

IPC分类号： G06N5/04

CPC分类号： G06N5/048 ,  G06N7/005 ,  G06Q10/047

摘要： Game theory models may be used for producing a strategy and schedule for patrolling an area like a rail transportation system. In some instances, the model may account for events that cause a patrol unit to deviate from a patrol schedule and route. For example, a patrol schedule may be generated for one or more patrol units using a Bayesian Stackelberg game theory model based on a map of the public transportation system, a schedule of the transports, a list of the one or more patrolling units, a probability distribution for the occurrence of the passenger not paying to ride the transports, a list of the one or more possible events that would delay the patrol units, and a probability distribution for the occurrence of the one or more possible events that would delay the patrolling units represented by a Markov-decision process.

摘要翻译： 游戏理论模型可用于制定巡视像铁路运输系统这样的区域的战略和时间表。 在某些情况下，该模型可能会导致巡视单位偏离巡逻进度和路线的事件。 例如，可以使用基于公共交通系统的地图，运输时间表，一个或多个巡逻单元的列表，一个或多个巡逻单元的列表，使用贝叶斯Stackelberg游戏理论模型来生成针对一个或多个巡逻单元的巡逻时间表 分配用于不支付乘坐运输工具的乘客的发生，将延迟巡逻单位的一个或多个可能的事件的列表，以及发生一个或多个可能的事件的概率分布，这些事件将延迟巡逻单位 由马尔科夫决定过程代表。

公开(公告)号：US08831013B2

公开(公告)日：2014-09-09

申请号：US12575608

申请日：2009-10-08

申请人： Sathish Kumar Gnanasekaran ,  Chao Zhang ,  Daniel Ji Yong Park Chung ,  Subramanian Lakshmanan ,  Badrinath Kollu

发明人： Sathish Kumar Gnanasekaran ,  Chao Zhang ,  Daniel Ji Yong Park Chung ,  Subramanian Lakshmanan ,  Badrinath Kollu

IPC分类号： H04L12/28 ,  H04W4/00 ,  H04L12/56 ,  H04L12/46

CPC分类号： H04L45/586 ,  H04L12/4625 ,  H04L45/583 ,  H04L49/357 ,  H04L49/70

摘要： A Layer 2 network switch is partitionable into a plurality of switch fabrics. The single-chassis switch is partitionable into a plurality of logical switches, each associated with one of the virtual fabrics. The logical switches behave as complete and self-contained switches. A logical switch fabric can span multiple single-chassis switch chassis. Logical switches are connected by inter-switch links that can be either dedicated single-chassis links or logical links. An extended inter-switch link can be used to transport traffic for one or more logical inter-switch links. Physical ports of the chassis are assigned to logical switches and are managed by the logical switch. Legacy switches that are not partitionable into logical switches can serve as transit switches between two logical switches.

摘要翻译： 二层网络交换机可分割成多个交换结构。 单机箱交换机可分割成多个逻辑交换机，每个逻辑交换机与虚拟结构之一相关联。 逻辑交换机表现为完整和自包含的交换机。 逻辑交换矩阵可以跨多个单机箱交换机机箱。 逻辑交换机通过可以是专用单机箱链路或逻辑链路的交换机间链路连接。 可以使用扩展的交换机间链路来传输一个或多个逻辑交换机间链路的业务。 机箱的物理端口分配给逻辑交换机，由逻辑交换机管理。 不可分割到逻辑交换机的旧式交换机可以用作两个逻辑交换机之间的转接交换机。

公开(公告)号：US08748601B2

公开(公告)日：2014-06-10

申请号：US12088059

申请日：2006-09-26

申请人： Jack Taunton ,  Michael Cohen ,  Kevan Shokat ,  Chao Zhang

发明人： Jack Taunton ,  Michael Cohen ,  Kevan Shokat ,  Chao Zhang

IPC分类号： C07D487/00 ,  C07D411/02 ,  C07D487/04

CPC分类号： C07D487/04 ,  C07D239/42 ,  C07D403/06 ,  C07D487/14 ,  C07D519/00

摘要： Inhibition of protein kinases having one or more cysteine residues within the ATP binding site is effected by contacting the kinase, per se or in a cell or subject, with an inhibitory-effective amount of a compound having a heterocyclic core structure comprised of two or more fused rings containing at least one nitrogen ring atom, and an electrophilic substituent that is capable of reacting with a cysteine residue within the ATP binding site of a kinase. Preferred compounds include certain pyrrolopyrimidines and oxindoles having such an electrophilic substituent and optionally an aromatic or heteroaromatic substituent that is capable of interacting with a threonine or smaller residue located in the gatekeeper position of the kinase. Kinases lacking such cysteine residues may be engineered or modified so that they are capable of being inhibited by such compounds by replacing a valine or other amino acid residue within the ATP binding site by a cysteine residue.

摘要翻译： 在ATP结合位点内具有一个或多个半胱氨酸残基的蛋白激酶的抑制通过使本身或细胞或受试者中的激酶与抑制有效量的具有由两个或更多个的杂环核心结构组成的化合物接触来实现 含有至少一个氮环原子的稠环，以及能够与激酶的ATP结合位点内的半胱氨酸残基反应的亲电取代基。 优选的化合物包括具有这样的亲电子取代基的某些吡咯并嘧啶和羟吲哚，以及任选的能够与位于激酶的关守位置的苏氨酸或更小残基相互作用的芳族或杂芳族取代基。 缺乏这种半胱氨酸残基的激酶可以被改造或修饰，使得它们能够被这种化合物抑制，通过用半胱氨酸残基替换ATP结合位点内的缬氨酸或其它氨基酸残基。

公开(公告)号：US20140122832A1

公开(公告)日：2014-05-01

申请号：US13995721

申请日：2012-10-25

申请人： Tin-Fook Ngai ,  Chunxiao Lin ,  Yingzhe Shen ,  Chao Zhang

发明人： Tin-Fook Ngai ,  Chunxiao Lin ,  Yingzhe Shen ,  Chao Zhang

IPC分类号： G06F9/30

CPC分类号： G06F9/30036 ,  G06F8/433 ,  G06F8/4441 ,  G06F8/452

摘要： Generally, this disclosure provides technologies for generating and executing partially vectorized code that may include backward dependencies within a loop body of the code to be vectorized. The method may include identifying backward dependencies within a loop body of the code; selecting one or more ranges of iterations within the loop body, wherein the selected ranges exclude the identified backward dependencies; and vectorizing the selected ranges. The system may include a vector processor configured to provide predicated vector instruction execution, loop iteration range enabling, and dynamic loop dependence checking.

摘要翻译： 通常，本公开提供了用于生成和执行部分向量化代码的技术，其可以包括要被矢量化的代码的循环体内的后向依赖性。 该方法可以包括识别代码的循环体内的后向依赖性; 在所述循环体内选择一个或多个迭代范围，其中所选择的范围排除所识别的后向依赖性; 并对所选范围进行向量化。 该系统可以包括被配置为提供预测向量指令执行，循环迭代范围使能和动态循环依赖性检查的向量处理器。

公开(公告)号：US08673928B2

公开(公告)日：2014-03-18

申请号：US12949741

申请日：2010-11-18

申请人： Prabha N. Ibrahim ,  Wayne Spevak ,  Hanna Cho ,  Songyuan Shi ,  Chao Zhang ,  Ying Zhang

发明人： Prabha N. Ibrahim ,  Wayne Spevak ,  Hanna Cho ,  Songyuan Shi ,  Chao Zhang ,  Ying Zhang

IPC分类号： C07D487/04 ,  A61K31/519 ,  A61P25/28 ,  A61P25/16 ,  A61P35/00 ,  A61P37/06 ,  A61P31/18

CPC分类号： C07D487/04 ,  A61K31/437 ,  A61K31/519 ,  A61K31/5377 ,  C07D401/04 ,  C07D403/04 ,  C07D471/04

摘要： and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds of Formula (I) or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on at least one Raf protein kinase. In certain aspects and embodiments, the described compounds are active in inhibiting proliferation of a Ras mutant cell line. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of B-Raf V600E mutant protein kinase, including melanoma, glioma, glioblastoma multiforme, pilocytic astrocytoma, colorectal cancer, thyroid cancer, lung cancer, ovarian cancer, prostate cancer, liver cancer, gallbladder cancer, gastrointestinal stromal tumors, biliary tract cancer, and cholangiocarcinoma. Also described are methods of use thereof to treat diseases and conditions, including diseases and conditions associated with activity of c-Raf-1 protein kinase, including acute pain, chronic pain or polycystic kidney disease.

摘要翻译： 及其盐，其制剂，其缀合物，其衍生物，其形式及用途。 在某些方面和实施方案中，所述式（I）化合物或其盐，其制剂，其缀合物，其衍生物，其形式在至少一种Raf蛋白激酶上具有活性。 在某些方面和实施方案中，所述化合物在抑制Ras突变细胞系的增殖中是有活性的。 还描述了其用于治疗疾病和病症的方法，包括与B-Raf V600E突变蛋白激酶（包括黑素瘤，神经胶质瘤，多形性成胶质细胞瘤，纤维细胞性星形细胞瘤，结肠直肠癌，甲状腺癌，肺癌，卵巢）的活动相关的疾病和病症 癌症，前列腺癌，肝癌，胆囊癌，胃肠道间质瘤，胆道癌和胆管癌。 还描述了其用于治疗疾病和病症的方法，包括与c-Raf-1蛋白激酶的活性相关的疾病和病症，包括急性疼痛，慢性疼痛或多囊肾病。